CRP levels have been used to predict the risk of cancer, detect cancer recurrence, and in prognosis. CRP is a biomarker of inflammation and indicator of the immune response to tumors. Its role as a predictor of survival has been shown in multiple myeloma, melanoma, lymphoma, ovarian, renal, pancreatic, and gastrointestinal tumors.